WASHINGTON, July 20 -- Centers for Medicare & Medicaid Services has issued a notice called: Medicare Program; Inflation Reduction Act of 2022 (IRA) Medicare Drug Price Negotiation Program Draft Guidance; Comment Request.
The notice was published in the Federal Register on July 20 by Chyana Woodyard, Federal Register Liaison, Centers for Medicare & Medicaid Services.
Summary: The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS' draft guidance for the Medicare Drug Price Negotiation Program regarding manufacturer effectuation of the maximum fair price in 2028 for the implementation of the Inflation Reduction Act of 2022 (IRA) (Pub. L. 117-169). CMS' draft guidance and other IRA-re...